cancer risk with semaglutide Can obesity meds also reduce risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked Frontiers | Reassessing cancer risk
Description
Oral semaglutide formulations for weight loss are launching alongside the injectables
aggressive tumors often use FAK signaling to invade surrounding tissue and seed metastases (secondary tumors) By boosting FAKpaxillin activity, BPC-157 might unwittingly give any lurking cancer cells a survival or migration advantage
How do GLP-1 injections work in the body
I am the burrito in the car person
It suppresses appetite by signaling fullness to the brain
